This trial tests new methods and materials for the real-time chemotherapy-associated side effects monitoring support system (RT-CAMSS) in patients with gastrointestinal cancers undergoing chemotherapy. RT-CAMSS is a monitoring support system that provides patients with evidence-based information and side-effect management and coping skills, emotional support and validation, and proactive care via text messages and questionnaires as they undergo chemotherapy.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Feasibility and Engagement
Timeframe: Up to 2 months or until chemotherapy is discontinued, whichever is earlier
Acceptability
Timeframe: Up to 2 months or until chemotherapy is discontinued, whichever is earlier
Symptom distress
Timeframe: Up to 2 months or until chemotherapy is discontinued, whichever is earlier
Self-efficacy
Timeframe: Up to 2 months or until chemotherapy is discontinued, whichever is earlier
Information and support needs
Timeframe: Prior to start of chemotherapy treatment
Medical information
Timeframe: Baseline
Functional Assessment of Cancer Treatment - General scale
Timeframe: Up to 2 months or until chemotherapy is discontinued, whichever is earlier
Social support
Timeframe: Up to 2 months or until chemotherapy is discontinued, whichever is earlier
Post-intervention evaluation
Timeframe: Through study completion, an average of 2 months